$5000 INSPIRATION AWARD
PANCREATIC CANCER- NOVEL THERAPEUTIC APPROACHES
APPLICATION DEADLINE: JULY 1,2022
Overview:
The Hopper-Belmont Foundation (“HBF”) Inspiration Award aims to motivate young
investigators to make a difference early in their career by providing a personal award
recognizing concepts and/ or projects in one of the following areas:
- Innovation: Recognition of an innovative idea in need of proof of concept/data
prior to applying for larger grants from NIH or other funding resources - Aspiration: Providing resources to begin, or further, research in the key HBF
focus area.
The use of the award is at the discretion of the winner, e.g. personal or research.
Since its launch in 2020, the annual Inspiration Award has attracted a competitive
field of excellent investigators and institutions across the United States and
internationally in the areas of pancreatic and pediatric cancers. Winners are profiled,
along with their research summary at www.hopperbelmont.org/award.
2022 Award: Application Focus: Pancreatic Cancer: Novel Therapeutic Approaches
with particular interest in (but not exclusive to) immunotherapy
The HBF welcomes and encourages applicants to be as innovative, out of the box, or
straightforward as you see fit. Acceptable application focus areas include: support of
existing projects; launch of new projects; funding of additional career
education/experience.
Who Qualifies: Post-doctoral (PhD, MD/PhD), Physicians-in-training (MD, MD/PhD), or
junior faculty members who are in the first two years of a faculty appointment at time of
application submission. Individual and team submissions are allowed.
Guidelines: Submit a concept summary (3 pages maximum) using the following format.
This should be in layman’s language to the extent possible (reviewers are both
healthcare professionals as well as patients/caregivers).
- Situation/Background
- Inspiration Idea (include relevance to immunotherapy if
applicable) - Proof of concept approach (if applicable)
- Overall benefits to the patient community
- Other potential concept applications (e.g impact on other
cancers; relevance to immunotherapy, etc) - Career aspirations the award may support
- Concept Timeline (if applicable)
- Closing remarks
- Appendix: To include
▪ NIH style bio sketch
▪ Recommendations. While not mandatory, letters of support from
current advisors, department heads, or other relevant individuals
are very helpful.
Inspiration Award Value: $5,000
Number of Awards: A minimum of two (2) awards to be granted to qualified
candidates. In 2020 the field was so excellent, the number of awards was expanded to
four and in 2021 three awards were granted.
Application Deadline: July 1, 2022
Applications should be submitted to hopperbelmontfoundation@hopperbelmont.org
Inspiration Award recipients agree to:
- Allow HBF to announce their award in various mediums
- If applicable, report results of the award to HBF within one year of award receipt
(informal is acceptable) - Provide a video summary of their research (examples can be found on
www.hopperbelmont.org/awards)
About the Hopper-Belmont Foundation: Hopper-Belmont Foundation (HBF) is a non
profit/ 501(c)(3) focused on identifying, motivating and supporting young investigators to
pursue innovative ideas in health and wellness. Founded in 2019 by leaders in non
profit research and patient advocacy foundations, the HBF intends to annually
recognize and fund exceptional talent to make a difference on a variety of topics. For
more information email inspiration@hopperbelmont.org
Federal Funding Opportunities
Department of Health and Human Services
National Institutes of Health
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
Synopsis 1
https://www.grants.gov/web/grants/view-opportunity.html?oppId=335529
Department of Health and Human Services
National Institutes of Health
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Synopsis 1
https://www.grants.gov/web/grants/view-opportunity.html?oppId=335530
Department of Health and Human Services
National Institutes of Health
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed)
Synopsis 1
https://www.grants.gov/web/grants/view-opportunity.html?oppId=335544
Department of Defense
Dept. of the Army — USAMRAA
DOD Chronic Pain Management, Translational Research Award
Synopsis 1
https://www.grants.gov/web/grants/view-opportunity.html?oppId=334180
Department of Defense
Dept. of the Army — USAMRAA
DOD Chronic Pain Management, Clinical Exploration Award
Synopsis 1
https://www.grants.gov/web/grants/view-opportunity.html?oppId=334177
Department of Defense
Dept. of the Army — USAMRAA
DOD Chronic Pain Management, Investigator-Initiated Research Award
Synopsis 1
https://www.grants.gov/web/grants/view-opportunity.html?oppId=334179
Department of Defense Pancreatic Cancer Research Program (PCARP)
Defense Health Program
Anticipated Funding Opportunities for Fiscal Year 2021 (FY21)
https://cdmrp.army.mil/pubs/press/2021/21pcarppreann
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
Department of Health and Human Services
National Institutes of Health
https://www.grants.gov/web/grants/view-opportunity.html?oppId=330177
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)
Department of Health and Human Services
National Institutes of Health
https://www.grants.gov/web/grants/view-opportunity.html?oppId=330179
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Department of Health and Human Services
National Institutes of Health
https://www.grants.gov/web/grants/view-opportunity.html?oppId=330178
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Department of Health and Human Services
National Institutes of Health
https://www.grants.gov/web/grants/view-opportunity.html?oppId=330159
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)
Department of Health and Human Services
National Institutes of Health
https://www.grants.gov/web/grants/view-opportunity.html?oppId=330161
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Department of Health and Human Services
National Institutes of Health
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
https://www.grants.gov/web/grants/view-opportunity.html?oppId=330160
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
National Institutes of Health
https://www.grants.gov/web/grants/view-opportunity.html?oppId=329929
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Department of Health and Human Services
National Institutes of Health
https://www.grants.gov/web/grants/view-opportunity.html?oppId=329928
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Department of Health and Human Services
National Institutes of Health
https://www.grants.gov/web/grants/view-opportunity.html?oppId=329947
National Cancer Institute’s Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
The purpose of this Funding Opportunity Announcement (FOA) is to seek research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of the National Cancer Institute’s (NCI) Division of Cancer Treatment and Diagnosis (DCTD). Applicants are strongly encouraged to consult the NCI DCTD website at https://dctd.cancer.gov/ to learn more about the various program goals, research priorities, and strategies developed to fight cancer. Applications submitted to this FOA must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. Applications that propose phase III clinical trials in any area of cancer research are not sought by and will not be supported through this FOA.
https://www.grants.gov/web/grants/view-opportunity.html?oppId=329803
Pancreatic Cancer Research Program (PCARP)
Defense Health Program
Department of Defense Pancreatic Cancer Research Program
Anticipated Funding Opportunities for Fiscal Year 2020 (FY20)